Polyoma virus: Old findings and new challenges

Virology

Volumn 289, Issue 2, 2001, Pages 167-173

  Benjamin, Thomas L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; CARCINOGENICITY; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; RAT; SHORT SURVEY; TUMOR GROWTH; VIRUS CELL INTERACTION; VIRUS CULTURE; VIRUS MUTANT; VIRUS STRAIN;

ANIMALIA; POLYOMAVIRUS;

EID: 0035950606     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1124     Document Type: Article

References (55)

1. Effects of antilymphocyte serum on virus oncogenesis
2. Increased susceptibility to virus oncogenesis of congenitally thymus-deprived nude mice
3. Different roles of two enhancer domains in the organ- and age-specific pattern of polyomavirus replication in the mouse
4. Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro
5. Genetic and structural analysis of a virulence determinant in polyomavirus VP1
6. Discrimination between sialic acid-containing receptors and pseudoreceptors regulates polyomavirus spread in the mouse
7. A determinant of polyomavirus virulence enhances virus growth in cells of renal origin
8. Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc
9. Functional analysis of the individual enhancer core sequences of polyomavirus: Cell-specific uncoupling of DNA replication from transcription
10. Identification of regions in polyomavirus middle T and small T antigens important for association with protein phosphatase 2A
11. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen
12. Radiation-resistant and radiation-sensitive forms of host resistance to polyomavirus
13. Roles of N-glycans with α2,6 as well as α2,3-linked sialic acid in infection of polyoma virus
14. Binding of p300/CBP co-activators by polyoma large T antigen
15. Polyomaviridae: The Viruses and Their Replication
16. Necrotizing arterial lesion in mice-bearing tumors induced by polyoma virus
17. Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles
18. Accelerated development of polyoma tumors and embryonic lethality: Different effects of p53 loss on related mouse backgrounds
19. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc
20. Polyomavirus large T antigen overcomes p53 dependent growth arrest
21. Middle T antigen activation of signal transduction pathways does not overcome p53-mediated growth arrest
22. Polyomavirus replication in mice: Influences of VP1 type and route of inoculation
23. Polyoma virus
24. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen
25. Host range and cell cycle activation properties of polyomavirus large T-antigen mutants defective in pRB binding
26. Separation of immortalization from tumor induction with polyoma large T mutants that fail to bind the retinoblastoma gene product
27. Polyomavirus tumor induction in mice: Effects of polymorphisms of VP1 and large T antigen
28. A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior
29. Duplication of noncoding sequences in polyomavirus specifically augments the development of thymic tumors in mice
30. Amino-terminal regions of polyomavirus middle T antigen are required for interactions with protein phosphatase 2A
31. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection
32. Etiology of cancer: DNA viruses
33. Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syngeneic lymphoid cells
34. Polyoma virus disrupts ARF signaling to p53
35. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen
36. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein
37. Antiviral CD8+ T cell responses in neonatal mice: Susceptibility to polyoma virus-included tumors is associated with lack of cytotoxic function by viral antigen-specific T cells
38. Polyomavirus large T antigen binds the transcriptional coactivator protein p300
39. Polyoma small and middle T antigens and SV40 small T antigen form stable complexes with protein phosphatase 2A
40. Regulation of cellular phenotype and expression of polyomavirus middle T antigen in rat fibroblasts
41. Genetic analysis of the enhancer requirements for polyomavirus DNA replication in mice
42. Minimal subenhancer requirements for high-level polyomavirus DNA replication: A cell-specific synergy of PEA3 and PEA1 sites
43. Enhancer dependence of polyomavirus persistence in mouse kidneys
44. Polyomavirus DNA replication in the pancreas and in a transformed pancreas cell line has distinct enhancer requirements
45. Karyotypic instability and viral integration in polyoma virus-induced mouse salivary gland tumors
46. Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment
47. Association of polyomavirus middle tumor antigen with phospholipase C-gamma 1
48. Acute, lethal, natural killer cell-resistant myeloproliferative disease induced polyomavirus in severe combined immunodeficient mice
49. Phosphorylation of middle T by pp60c-src: A switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis
50. The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice
51. Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein
52. Wild-derived inbred mice have a novel basis of susceptibility to polyoma virus induced tumors
53. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation
54. Organ- and age-specific replication of polyomavirus in mice